Ventyx Biosciences, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 12790 EL CAMINO REAL, SUITE 200, SAN DIEGO, CA, 92130
Mailing Address 12790 EL CAMINO REAL, SUITE 200, SAN DIEGO, CA, 92130
Phone 7604076511
Fiscal Year End 1231
EIN 832996852
Financial Overview
FY2024
$33.77M
Total Liabilities
$353.89M
Stockholders' Equity
$51.58M
Cash & Equivalents
$-1.97
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 6, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 5, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 29, 2026 | View on SEC |
| 8-K Current report of material events | January 22, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 9, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 9, 2026 | View on SEC |
| 8-K Current report of material events | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | December 19, 2025 | View on SEC |
| 4 Insider stock transaction report | December 19, 2025 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | November 26, 2025 | View on SEC |
Material Events
8-K Acquisition January 22, 2026
High Impact
- Ventyx Biosciences is being acquired by pharmaceutical giant Eli Lilly and Company.
- Special cash retention bonuses are approved for CEO Raju Mohan (up to $2,000,000) and other key executives to ensure a smooth transition and retain talent.
Insider Trading
SELL 2 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.